文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

注射毒品网络特征作为注射行为的预测指标。

Injection drug network characteristics as a predictor of injection behaviour.

机构信息

Burnet Institute,Melbourne,Australia.

出版信息

Epidemiol Infect. 2019 Jan;147:e173. doi: 10.1017/S095026881900061X.


DOI:10.1017/S095026881900061X
PMID:31063105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6518653/
Abstract

Social network characteristics of people who inject drugs (PWID) have previously been flagged as potential risk factors for HCV transmission such as increased injection frequency. To understand the role of the injecting network on injection frequency, we investigated how changes in an injecting network over time can modulate injecting risk behaviour. PWID were sourced from the Networks 2 Study, a longitudinal cohort study of PWID recruited from illicit drug street markets across Melbourne, Australia. Network-related correlates of injection frequency and the change in frequency over time were analysed using adjusted Cox Proportional Hazards and Generalised Estimating Equations modelling. Two-hundred and eighteen PWID followed up for a mean (s.d.) of 2.8 (1.7) years were included in the analysis. A greater number of injecting partners, network closeness centrality and eigenvector centrality over time were associated with an increased rate of infection frequency. Every additional injection drug partner was associated with an increase in monthly injection frequency. Similarly, increased network connectivity and centrality over time was also associated with an increase in injection frequency. This study observed that baseline network measures of connectivity and centrality may be associated with changes in injection frequency and, by extension, may predict subsequent HCV transmission risk. Longitudinal changes in network position were observed to correlate with changes in injection frequency, with PWID who migrate from the densely-connected network centre out to the less-connected periphery were associated with a decreased rate of injection frequency.

摘要

社交网络特征的吸毒者(PWID) 此前被标记为 HCV 传播的潜在风险因素,如增加注射频率。为了了解注射网络对注射频率的作用,我们研究了随着时间的推移,注射网络的变化如何调节注射风险行为。PWID 来源于网络 2 研究,这是一项在澳大利亚墨尔本非法毒品街头市场招募的吸毒者的纵向队列研究。使用调整后的 Cox 比例风险和广义估计方程模型分析了与注射频率相关的网络相关因素以及随时间变化的频率变化。在平均(标准差)为 2.8(1.7)年的随访中,有 218 名 PWID 纳入分析。随着时间的推移,更多的注射伙伴、网络紧密中心性和特征向量中心性与感染频率的增加率相关。每个额外的注射药物伙伴与每月注射频率的增加有关。同样,随着时间的推移,网络连通性和中心性的增加也与注射频率的增加有关。这项研究观察到,基线网络连通性和中心性的衡量标准可能与注射频率的变化有关,并且可以预测 HCV 传播风险。观察到网络位置的纵向变化与注射频率的变化相关,从密集连接的网络中心迁移到连接较少的外围的 PWID 与注射频率降低的速率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a2/6518653/b597a901de73/S095026881900061X_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a2/6518653/b597a901de73/S095026881900061X_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a2/6518653/b597a901de73/S095026881900061X_fig1.jpg

相似文献

[1]
Injection drug network characteristics as a predictor of injection behaviour.

Epidemiol Infect. 2019-1

[2]
Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.

Int J Drug Policy. 2015-8-22

[3]
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.

J Epidemiol Community Health. 2015-8

[4]
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.

Int J Drug Policy. 2014-1

[5]
Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.

Afr J AIDS Res. 2018-9

[6]
Hepatitis C transmission and treatment as prevention - The role of the injecting network.

Int J Drug Policy. 2015-5-21

[7]
Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.

Int J Drug Policy. 2017-7-3

[8]
Modelling hepatitis C transmission over a social network of injecting drug users.

J Theor Biol. 2011-12-16

[9]
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.

Int J Drug Policy. 2015-10

[10]
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).

BMC Public Health. 2016-9-5

引用本文的文献

[1]
Leveraging Injection Networks to Prevent HIV and Other Blood Borne Infections Among People Who Inject Drugs in Kenya: Design and Rationale.

Res Sq. 2025-8-20

[2]
Perceived Social Isolation and Fentanyl Use Among Adults Who Inject Drugs in Rural Kentucky.

Soc Work Public Health. 2025-5-19

[3]
Differences in characteristics and interactions with close contacts among PWID in the San Diego Border Region before and during the COVID-19 pandemic.

J Migr Health. 2024-9-24

[4]
Network centrality and HIV prevention service use among people who inject drugs: Findings from a sociometric network cohort in New Delhi, India.

Addiction. 2024-3

[5]
Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs.

Pathogens. 2023-2-15

[6]
Finding influential subjects in a network using a causal framework.

Biometrics. 2023-12

[7]
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic.

Int J Drug Policy. 2022-12

[8]
Deep learning and social network analysis elucidate drivers of HIV transmission in a high-incidence cohort of people who inject drugs.

Sci Adv. 2022-10-21

[9]
Systematic Review of Hepatitis C Virus Prevalence in the WHO Western Pacific Region.

Viruses. 2022-7-15

[10]
Level and correlates of social support in a community-based sample of Australians who primarily smoke methamphetamine.

Health Soc Care Community. 2022-11

本文引用的文献

[1]
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Cochrane Database Syst Rev. 2017-9-18

[2]
Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Virulence. 2016

[3]
The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs.

Hepatology. 2014-10-24

[4]
Global epidemiology and genotype distribution of the hepatitis C virus infection.

J Hepatol. 2014-7-30

[5]
Outlier populations: individual and social network correlates of solvent-using injection drug users.

PLoS One. 2014-2-11

[6]
Hepatitis C transmission and treatment in contact networks of people who inject drugs.

PLoS One. 2013-11-1

[7]
Eradication of hepatitis C infection: the importance of targeting people who inject drugs.

Hepatology. 2014-2

[8]
Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.

Am J Public Health. 2012-11-15

[9]
Social networks and HCV viraemia in anti-HCV-positive rural drug users.

Epidemiol Infect. 2012-4-19

[10]
Modelling hepatitis C transmission over a social network of injecting drug users.

J Theor Biol. 2011-12-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索